CBD marketing in 2026: which ads Meta, Google and TikTok allow by product type, the FDA and FTC rules, and how creators and programmatic carry the rest.
The short answer
CBD marketing in 2026 runs on owned channels, creators, programmatic and one narrow paid-social lane, because Google, Meta and TikTok restrict or ban CBD ads by product form. Topical CBD can run on Meta and Google with LegitScript certification. Ingestible CBD cannot run as a paid ad on any of the three. Email, creators and retail media carry the rest.
Key takeaways
Most CBD marketing advice is written by agencies that want the retainer, so it lists eleven channels and commits to none. This page does the opposite. It tells you, product form by product form, what each platform will clear, what the FDA and FTC will let you say, and where brands in this category actually spend once the paid-social door half closes.
Two facts shape everything below. The first is that a balm and a gummy are different products in the eyes of every ad platform, even when they come from the same jar of extract. The second is that the FTC does not care which channel a claim ran on. A creator saying "it cured my anxiety" in a Reel is your claim, and your problem.
CBD marketing is the promotion of hemp-derived cannabidiol products (topicals, tinctures, gummies, capsules, pet products) under a rule set that bans disease claims and restricts paid advertising by product form. It is different from ordinary DTC marketing because the two biggest paid channels, Meta and Google, review CBD ads against a stricter policy than the one they apply to a moisturizer or a protein powder.
Three regulators and three platforms set the boundaries. The FDA governs what a label and a product claim may say, and it treats a claim that CBD treats, cures or prevents a condition as an unapproved drug claim. The FTC governs advertising and requires that every objective claim, express or implied, is backed by competent and reliable scientific evidence. Its Health Products Compliance Guidance replaced the 1998 supplement guide in December 2022 and draws on more than 200 settled cases. State law adds a third layer, with different rules on THC thresholds and labeling by state.
Then the platforms. Meta, Google and TikTok each publish a CBD policy, and each one splits the world into ingestible and non-ingestible. That split matters more than your brand story, your budget or your creative. The sections below take the three platforms one at a time.
Yes, for topical and other non-ingestible CBD products, once you hold LegitScript certification and Meta has issued written approval for your ad account. No, for ingestible CBD in any form. That is the whole answer for Meta, and it has been the answer since Meta's July 2023 policy update for the US, Canada and Mexico.
Balms, salves, roll-ons and cosmetics at 0.3% THC or below, advertised by a certified account, targeted to adults 18 and over. Hemp products that contain no CBD (seed, fiber, hemp-based textiles) can run without written permission in the three markets. Educational or advocacy content about hemp that does not sell a specific product also runs without prior approval.
Oils, tinctures, gummies, capsules, beverages, anything you swallow. Any health claim, including the soft ones ("calming", "helps you unwind") when they are attached to a product. Interest targeting built around a health condition. Running before the approval lands, even if the product qualifies.
Page approval and ad approval are different reviews. A CBD brand can post organically on Instagram for two years without incident and still have its first paid campaign rejected, because the ad policy team reads copy for health claims and the personal-attributes rule that organic content never faced. Get the certification, then apply for written approval, then build creative. In that order.
Meta's current rules live in its Drugs and Pharmaceuticals ad standard. Policy in this category has moved twice in three years. Check it before each campaign, and confirm with a lawyer if the product form is borderline.
You can post about CBD on TikTok organically. You cannot run a self-serve TikTok ad for it. TikTok's healthcare and pharmaceuticals policy states that hemp products are not supported through self-serve and require a TikTok sales representative, that topical CBD cosmetics are permitted only in some markets, and that ingestible hemp products are prohibited.
For a typical DTC CBD brand, treat TikTok as an earned channel. Three moves work.
Organic distribution on TikTok still rewards volume and variety more than any other platform in this category. Ten to twenty posts a month across ingredient education, sourcing, lab testing and routine content gives the algorithm enough to work with.
Creators discussing hemp sourcing, third-party testing or how they use a topical after a run stay inside what TikTok distributes. Creators promising sleep, pain relief or anxiety relief get the post removed and put the brand on a list.
Boosting a compliant organic post through Spark Ads follows a different review path than a cold ad built in Ads Manager. It is not a loophole (the same content rules apply), but a post TikTok already distributed organically is a post TikTok already read.
TikTok Shop is a separate question with separate rules, and CBD is not a category it supports for US sellers at the time of writing. If that changes, this page will be updated.
Only topical CBD, only with LegitScript certification, and only to California, Colorado and Puerto Rico under Google's current healthcare policy. FDA-approved CBD pharmaceuticals are a separate case. Ingestible CBD (oils, gummies, capsules), inhalants and any THC product cannot be advertised on Google Ads.
Two practical notes from brands that have been through it. Performance Max and Shopping campaigns get a harder review than standard Search, because Google reviews the product feed and the landing page as well as the ad. And the LegitScript certificate is per product category, with a Certificate of Analysis required for each one, a website compliance review (no drug claims, compliant disclaimers) and an annual renewal fee. Budget several weeks and a four-figure fee before the first Google click.
The Google Ads healthcare and medicines policy is the source of record. YouTube inherits the same policy, so a YouTube pre-roll for a CBD gummy is not a workaround.
Three sets of rules apply to every CBD ad in the US, whatever the channel. The FDA's rules on what a product can claim. The FTC's rules on what an ad can claim and how it must be substantiated. And state rules on THC limits, labeling and where hemp products may be sold.
A statement that CBD treats, cures, mitigates or prevents a disease or condition makes the product an unapproved drug in the FDA's view. "Relieves arthritis pain", "treats anxiety", "helps with insomnia" are all disease claims. The FDA has sent warning letters to CBD companies for exactly this language on websites and social media.
Any objective claim about a health benefit needs competent and reliable scientific evidence before the ad runs. Testimonials count as claims. A customer saying "my knee pain was gone in ten minutes" in your ad implies that result is typical, and you need the evidence to back what it implies. The FTC's Health Products Compliance Guidance walks through how it reads express and implied claims.
Any named condition. Any drug-style outcome ("pain relief", "anti-anxiety", "sleep aid"). "FDA approved" (no CBD supplement is). "Clinically proven" without the clinical trial to show for it. Dosing advice framed as treatment. And any claim a creator makes in your campaign that you could not make yourself.
What the product is and how it is made: USA-grown hemp, CO2 extraction, third-party lab tested, THC below 0.3%, ingredient list, texture, scent. How to use it. Who makes it and why. Where it is sold. Reviews, as long as they are real and do not smuggle in disease claims. This is thinner material than a benefit claim, and it is the material compliant CBD brands build their whole creative library on.
None of this is legal advice. It is the shape of the rules as published. A regulatory lawyer should read your claims sheet before anything ships.
With paid social narrowed to topicals and Google narrowed to three states, the media plan for a CBD brand looks different from a beauty brand's. The channels below carry most of the spend, in roughly the order brands add them.
No platform ad policy applies. The FTC substantiation rule still does. For a subscription product like CBD, this is usually the highest-volume channel by revenue and the cheapest to run.
Covered in the next section. This is the channel that reaches new customers at scale in this category, and the one with the highest compliance risk per post.
Demand-side platforms such as Viant, StackAdapt and The Trade Desk sell access to publisher inventory that accepts CBD, with contextual and household targeting instead of health-interest segments. Many exchanges still ask for LegitScript-style certification, but the review sits with the publisher, not with one platform's blanket policy. This is where the largest CBD advertisers spend, and it is invisible in a Meta Ad Library search, which is why most guides skip it.
If the product sells through a retailer with an ad network, you can advertise where it is sold. Amazon's stance on CBD has shifted over the years and remains restrictive for most ingestibles, so check the retailer's current policy rather than assuming.
Organic search is open to CBD in a way paid search is not. Ranking for ingredient, sourcing and how-to-use queries is slow work, and it compounds.
Notice what is not on this list as a growth channel: cold paid social for a gummy. Brands that keep trying to make that work burn ad accounts, then start over with a new business manager, and the cycle repeats until the domain is flagged.
Creator content is how most CBD brands reach new buyers, because it moves through organic distribution and does not pass through the paid-ads review queue. It is also where compliant brands get into trouble, because a creator improvising on camera will reach for the benefit language you spent a year avoiding.
Follower count tells you little. A profile with 112K followers averaging 9.6K views has a view rate around 8.6%, and a real cost per thousand views you can calculate before you pay. Strip out bot and bought engagement first. Then read the creator's back catalog for health claims. A creator who has promised sleep from a gummy for another brand will do it for yours.
Give the creator the exact approved lines and the exact banned words. "USA-grown hemp, third-party tested" is approved. "Helps me sleep" is banned. Synonyms are banned too, because "helps me wind down" is the same claim in softer clothes. Put it in the contract as well as the brief.
The FTC's Disclosures 101 is clear that a disclosure must sit with the endorsement, in the video as well as the caption, and outside the hashtag pile. Advertisers are expected to monitor. A creator's missed disclosure is a brand's problem in an enforcement action.
The claim can be in the voiceover, the on-screen text, the caption or the product shot with a "pain relief" label facing the camera. A frame-by-frame review catches what a script read does not. Slow, and cheaper than a warning letter.
Run this way, creators are a durable channel for CBD. Run on a hunch and a follower count, they are the fastest route to a platform ban and a regulator's attention. Our own influencer agent page walks through how we source, screen and brief creators, including the fraud screening step.
QuickAds is a performance-creative company, and CBD is one of the regulated categories we build for. Two parts of what we do matter here.
The first is creator sourcing and management through Remy, our influencer agent. Remy searches Instagram, YouTube and TikTok on a plain-English brief, strips bot and fake engagement, ranks creators on real view rate and cost per thousand views rather than follower count, then runs outreach and rate negotiation from your own handle under a cap you set. Creators typically reply within one to two days, and the brief-to-delivery cycle runs five to seven days. For CBD, the brief is built from your approved claims sheet, and every delivered video is reviewed against it before you see it.
The second is claims-safe creative at volume. We hold your approved claim statements as a library (verbatim, no synonyms), build ad concepts from those blocks plus our own library of hooks trained on 32M+ ads, then review the output frame by frame and flag anything that is not ready. That gives a CBD brand 100+ creatives a month on a 5 to 7 day turnaround without the claim drifting between the Meta topical campaign, the creator posts and the programmatic buy. How the production side works is on creative as a service.
What we do not do: LegitScript certification (that is between you and LegitScript), Meta's written approval process (we can help you prepare it, you submit it), or legal review. A regulatory lawyer signs off on your claims sheet. We work inside it.
Software starts at $299 per month. A managed regulated-category program runs $2,000 to $5,000 per month depending on scope. If you searched for a CBD marketing agency or a CBD marketing company, this is the part of the work we do, and how the engagement runs is on its own page. Related reading in this cluster: supplement marketing, weight loss advertising for GLP-1 brands, and influencer marketing compliance. Our D2C health and wellness ads report covers what is running in the wider category.
Yes, for topical and other non-ingestible CBD at 0.3% THC or below, once you have LegitScript certification and written approval from Meta for your ad account, targeted to adults 18 and over. Ingestible CBD (oils, gummies, capsules, drinks) cannot be advertised on Facebook or Instagram. Hemp products with no CBD can run without written permission in the US, Canada and Mexico.
You can post about CBD organically on TikTok, but you cannot run a self-serve TikTok ad for it. TikTok's policy routes hemp products through a sales representative, allows topical CBD cosmetics only in some markets and prohibits ingestible hemp products outright. Most CBD brands treat TikTok as an organic and creator channel, then use Spark Ads to boost posts that already performed.
Only topical CBD products, only with LegitScript certification, and only targeted to California, Colorado and Puerto Rico under Google's healthcare policy. Ingestible CBD, inhalants and THC products cannot be advertised on Google Ads or YouTube. Performance Max and Shopping campaigns receive a stricter review than standard Search because Google reviews the product feed and landing page as well as the ad.
Three layers apply. The FDA treats any claim that CBD treats, cures or prevents a condition as an unapproved drug claim. The FTC requires competent and reliable scientific evidence for every objective health claim, including claims implied by testimonials and creator content. State law sets THC thresholds and labeling rules. Platform policies from Meta, Google and TikTok sit on top, restricting paid ads by product form.
Do not name a condition (pain, anxiety, insomnia, arthritis), promise a drug-style outcome, say "FDA approved", or say "clinically proven" without a trial to cite. Do not let a creator say any of those on your behalf either. What you can say is what the product is and how it is made: USA-grown hemp, CO2 extraction, third-party tested, THC under 0.3%, ingredients, texture and how to use it.
The CBD ads that run without rejection describe the product and its making rather than an outcome: a topical shown in use after a workout with the ingredient list on screen, a lab-test walkthrough, a founder explaining the sourcing, a creator showing where the balm sits in a morning routine. The format that fails is a jar next to a promise. Effective here means it clears review and keeps running, which is the first condition for anything else.